ARCHIVES

Letter to the Editors: Scientists, Media Shouldn’t Overstate “Breakthroughs”

This article is from The Cancer Letter archive.

Vol. 24 No. 21 | May 29, 1998

Download PDF Visit The Full Archive

Related Articles

FDA Approves Generic Capecitabine

September 20, 2013

NCI Chips In $2 Million For AACR Meeting; Advisors, Senior Staff Not Consulted.

June 20, 2003

MUSC Hollings Cancer Center awarded NCI designation

February 1, 2021

Cancer Control RFA Announcements

March 9, 1979

NCI Considering Combining Support, Control Core Grants; Directors Reject Two Grants, One Review

June 2, 1978

Hammer Goes Public With Appeal for Increased Funding

March 14, 1986